Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand
- 4 September 1991
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 202 (1) , 89-91
- https://doi.org/10.1016/0014-2999(91)90257-q
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sitesEuropean Journal of Pharmacology, 1991
- The serotonin 5-HT1D receptor: A progress reviewNeurochemical Research, 1990
- 5‐HT1D binding sites in porcine brain can be sub‐divided by GR43175British Journal of Pharmacology, 1989
- 5‐Hydroxytryptamine receptor “families”The FASEB Journal, 1989
- Detection of a Novel Serotonin Receptor Subtype (5‐HT1E) in Human Brain: Interaction with a GTP‐Binding ProteinJournal of Neurochemistry, 1989
- The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigraNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranesJournal of Neuroscience, 1987
- Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]KetanserinEuropean Journal of Pharmacology, 1985